Jamie H Thompson1, Melinda M Davis2, Michael C Leo3, Jennifer L Schneider4, David H Smith5, Amanda F Petrik6, Melissa Castillo7, Brittany Younger8, Gloria D Coronado9. 1. The Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, Oregon 97227, USA. Electronic address: jamie.h.thompson@kpchr.org. 2. Oregon Rural Practice-based Research Network (ORPRN), Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239, USA. Electronic address: davismel@ohsu.edu. 3. The Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, Oregon 97227, USA. Electronic address: michael.c.leo@kpchr.org. 4. The Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, Oregon 97227, USA. Electronic address: jennifer.l.schneider@kpchr.org. 5. The Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, Oregon 97227, USA. Electronic address: david.h.smith@kpchr.org. 6. The Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, Oregon 97227, USA. Electronic address: amanda.f.petrik@kpchr.org. 7. AltaMed, 2040 Camfield Avenue, Los Angeles, CA 90040, USA. Electronic address: mdycus@altamed.org. 8. AltaMed, 2040 Camfield Avenue, Los Angeles, CA 90040, USA. Electronic address: byounger@altamed.org. 9. The Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, Oregon 97227, USA. Electronic address: gloria.d.coronado@kpchr.org.
Abstract
BACKGROUND: Colon cancer is the second leading cause of cancer deaths in the United States. The Participatory Research to Advance Colon Cancer Prevention (PROMPT) study is a collaboration between two research institutions and a federally qualified health center (FQHC). The study seeks to raise colon cancer screening rates using a direct-mail fecal immunochemical testing (FIT) and reminder program in an FQHC serving a predominantly Latino population in California. METHODS: PROMPT is a pragmatic trial enrolling 16 clinics. The study will test automated and live prompts (i.e., alerts, reminders) to a direct-mail FIT program in two phases. In Phase I, we tailored and defined intervention components for the pilot using a community-based participatory research approach called boot camp translation. We then plan to conduct a three-arm patient-randomized comparative effectiveness trial in two pilot clinics to compare 1) automated prompts, 2) live prompts, and 3) a combination of automated plus live prompts to alert and remind patients to complete screening. In Phase II, the adapted best practice intervention will be spread to additional clinics within the FQHC (estimated population 27,000) and assessed for effectiveness. Patient and staff interviews will be conducted to explore receptivity to the program and identify barriers to implementation. DISCUSSION: This pragmatic trial applies innovative approaches to engage diverse stakeholders and will test the effectiveness and spread of a direct-mail plus reminder program. If successful, the program will provide a model for a cost-effective method to raise colon cancer screening rates among Latino patients receiving care in FQHCs. TRIAL REGISTRATION: National Clinical Trial (NCT) Identifier NCT03167125.
RCT Entities:
BACKGROUND:Colon cancer is the second leading cause of cancer deaths in the United States. The Participatory Research to Advance Colon Cancer Prevention (PROMPT) study is a collaboration between two research institutions and a federally qualified health center (FQHC). The study seeks to raise colon cancer screening rates using a direct-mail fecal immunochemical testing (FIT) and reminder program in an FQHC serving a predominantly Latino population in California. METHODS: PROMPT is a pragmatic trial enrolling 16 clinics. The study will test automated and live prompts (i.e., alerts, reminders) to a direct-mail FIT program in two phases. In Phase I, we tailored and defined intervention components for the pilot using a community-based participatory research approach called boot camp translation. We then plan to conduct a three-arm patient-randomized comparative effectiveness trial in two pilot clinics to compare 1) automated prompts, 2) live prompts, and 3) a combination of automated plus live prompts to alert and remind patients to complete screening. In Phase II, the adapted best practice intervention will be spread to additional clinics within the FQHC (estimated population 27,000) and assessed for effectiveness. Patient and staff interviews will be conducted to explore receptivity to the program and identify barriers to implementation. DISCUSSION: This pragmatic trial applies innovative approaches to engage diverse stakeholders and will test the effectiveness and spread of a direct-mail plus reminder program. If successful, the program will provide a model for a cost-effective method to raise colon cancer screening rates among Latino patients receiving care in FQHCs. TRIAL REGISTRATION: National Clinical Trial (NCT) Identifier NCT03167125.
Authors: Theresa L Byrd; Katherine M Wilson; Judith Lee Smith; Andrea Heckert; Carlyn E Orians; Sally W Vernon; Maria E Fernandez-Esquer; Maria E Fernandez Journal: Health Educ Behav Date: 2012-03-01
Authors: Ned Norman; Chris Bennett; Shirley Cowart; Maret Felzien; Martha Flores; Rafael Flores; Connie Haynes; Mike Hernandez; Mary Petra Rodriquez; Norah Sanchez; Sergio Sanchez; Kathy Winkelman; Steve Winkelman; Linda Zittleman; John M Westfall Journal: J Am Board Fam Med Date: 2013 May-Jun Impact factor: 2.657
Authors: Laurie E Steffen; Kenneth M Boucher; Barbara H Damron; Lisa M Pappas; Scott T Walters; Kristina G Flores; Watcharaporn Boonyasiriwat; Sally W Vernon; Antoinette M Stroup; Marc D Schwartz; Sandra L Edwards; Wendy K Kohlmann; Jan T Lowery; Charles L Wiggins; Deirdre A Hill; John C Higginbotham; Randall Burt; Rebecca G Simmons; Anita Y Kinney Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-22 Impact factor: 4.254
Authors: Susan M Rawl; Shannon M Christy; Patrick O Monahan; Yan Ding; Connie Krier; Victoria L Champion; Douglas Rex Journal: Health Educ Res Date: 2015-05-28
Authors: David W Baker; Tiffany Brown; David R Buchanan; Jordan Weil; Kate Balsley; Lauren Ranalli; Ji Young Lee; Kenzie A Cameron; M Rosario Ferreira; Quinn Stephens; Shira N Goldman; Alred Rademaker; Michael S Wolf Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Gloria D Coronado; William M Vollmer; Amanda Petrik; Josue Aguirre; Tanya Kapka; Jennifer Devoe; Jon Puro; Tran Miers; Jennifer Lembach; Ann Turner; Jennifer Sanchez; Sally Retecki; Christine Nelson; Beverly Green Journal: BMC Cancer Date: 2014-02-26 Impact factor: 4.430
Authors: Gloria D Coronado; Jennifer S Rivelli; Morgan J Fuoco; William M Vollmer; Amanda F Petrik; Erin Keast; Sara Barker; Emily Topalanchik; Ricardo Jimenez Journal: J Gen Intern Med Date: 2017-10-10 Impact factor: 5.128
Authors: Sheila F Castañeda; Balambal Bharti; Marielena Rojas; Silvia Mercado; Adriana M Bearse; Jasmine Camacho; Manuel Song Lopez; Fatima Muñoz; Shawne O'Connell; Lin Liu; Gregory A Talavera; Samir Gupta Journal: Am J Public Health Date: 2020-02-20 Impact factor: 9.308
Authors: Gloria D Coronado; Jamie H Thompson; Amanda F Petrik; Denis B Nyongesa; Michael C Leo; Melissa Castillo; Brittany Younger; Anne Escaron; Alex Chen Journal: J Am Board Fam Med Date: 2019 May-Jun Impact factor: 2.657
Authors: Jamie H Thompson; Melinda M Davis; LeAnn Michaels; Jennifer S Rivelli; Melissa L Castillo; Brittany M Younger; Marta Castro; Sacha L Reich; Gloria D Coronado Journal: J Am Board Fam Med Date: 2019 May-Jun Impact factor: 2.657
Authors: Melinda M Davis; Jennifer L Schneider; Amanda F Petrik; Edward J Miech; Brittany Younger; Anne L Escaron; Jennifer S Rivelli; Jamie H Thompson; Denis Nyongesa; Gloria D Coronado Journal: Ann Fam Med Date: 2022 Mar-Apr Impact factor: 5.166
Authors: Melinda M Davis; Jennifer L Schneider; Rose Gunn; Jennifer S Rivelli; Katherine A Vaughn; Gloria D Coronado Journal: Transl Behav Med Date: 2021-03-16 Impact factor: 3.046
Authors: Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone Journal: CA Cancer J Clin Date: 2020-06-25 Impact factor: 286.130
Authors: Gloria D Coronado; Michael C Leo; Katrina Ramsey; Jennifer Coury; Amanda F Petrik; Mary Patzel; Erin S Kenzie; Jamie H Thompson; Erik Brodt; Raj Mummadi; Nancy Elder; Melinda M Davis Journal: Implement Sci Commun Date: 2022-04-13
Authors: Gloria D Coronado; Denis B Nyongesa; Amanda F Petrik; Jamie H Thompson; Anne L Escaron; Brittany Younger; Shelby Harbison; Michael C Leo Journal: Clin Gastroenterol Hepatol Date: 2020-07-30 Impact factor: 13.576